PubMed

Targeting TNF-alpha for cancer therapy.

Burton ER, Libutti SK.

J Biol. 2009 Oct 23;8(9):85.PMID: 19863762 [PubMed - in process]Related articlesFree article

A novel peptide (GX1) homing to gastric cancer vasculature inhibits angiogenesis and cooperates with TNF alpha in anti-tumor therapy.

Chen B, Cao S, Zhang Y, Wang X, Liu J, Hui X, Wan Y, Du W, Wang L, Wu K, Fan D.

BMC Cell Biol. 2009 Sep 9;10:63.PMID: 19740430 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical use of therapies targeting tumor vasculature and stroma.

Davis ID, Desai J.

Curr Cancer Drug Targets. 2008 Sep;8(6):498-508. Review.PMID: 18781896 [PubMed - indexed for MEDLINE]Related articles

Specific targeting of the vasculature of gastric cancer by a new tumor-homing peptide CGNSNPKSC.

Hui X, Han Y, Liang S, Liu Z, Liu J, Hong L, Zhao L, He L, Cao S, Chen B, Yan K, Jin B, Chai N, Wang J, Wu K, Fan D.

J Control Release. 2008 Oct 21;131(2):86-93. Epub 2008 Jul 23.PMID: 18700158 [PubMed - indexed for MEDLINE]Related articles

Evading tumor evasion: Current concepts and perspectives of anti-angiogenic cancer therapy.

Abdollahi A, Folkman J.

Drug Resist Updat. 2010 Jan 8. [Epub ahead of print]PMID: 20061178 [PubMed - as supplied by publisher]Related articles

Tumor necrosis factor and cancer, buddies or foes?

Wang X, Lin Y.

Acta Pharmacol Sin. 2008 Nov;29(11):1275-88. Review.PMID: 18954521 [PubMed - indexed for MEDLINE]Related articlesFree article

Integrin alpha v beta 3 antagonists for anti-angiogenic cancer treatment.

Hsu AR, Veeravagu A, Cai W, Hou LC, Tse V, Chen X.

Recent Pat Anticancer Drug Discov. 2007 Jun;2(2):143-58. Review.PMID: 18221059 [PubMed - indexed for MEDLINE]Related articles

The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells.

Kulbe H, Hagemann T, Szlosarek PW, Balkwill FR, Wilson JL.

Cancer Res. 2005 Nov 15;65(22):10355-62.PMID: 16288025 [PubMed - indexed for MEDLINE]Related articlesFree article

Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.

Scherf U, Benhar I, Webber KO, Pastan I, Brinkmann U.

Clin Cancer Res. 1996 Sep;2(9):1523-31.PMID: 9816329 [PubMed - indexed for MEDLINE]Related articlesFree article

Pathway-specific profiling identifies the NF-kappa B-dependent tumor necrosis factor alpha-regulated genes in epidermal keratinocytes.

Banno T, Gazel A, Blumenberg M.

J Biol Chem. 2005 May 13;280(19):18973-80. Epub 2005 Feb 18.PMID: 15722350 [PubMed - indexed for MEDLINE]Related articlesFree article

Combining tumstatin45-132 with tumor necrosis factor-alpha improves Its antineoplastic activity.

Luo YQ, Wang LH, Qiu Y, Jiao BH.

J Hepatol. 2005 Sep 15. [Epub ahead of print]PMID: 16510202 [PubMed - as supplied by publisher]Related articles

Tumor necrosis factor-alpha in cardiovascular biology and the potential role for anti-tumor necrosis factor-alpha therapy in heart disease.

Sack M.

Pharmacol Ther. 2002 Apr-May;94(1-2):123-35. Review.PMID: 12191598 [PubMed - indexed for MEDLINE]Related articles

Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.

Yasuda H.

Nitric Oxide. 2008 Sep;19(2):205-16. Epub 2008 May 6. Review.PMID: 18503779 [PubMed - indexed for MEDLINE]Related articles

Tumor vasculature-targeted delivery of tumor necrosis factor-alpha.

Tandle A, Hanna E, Lorang D, Hajitou A, Moya CA, Pasqualini R, Arap W, Adem A, Starker E, Hewitt S, Libutti SK.

Cancer. 2009 Jan 1;115(1):128-39.PMID: 19090007 [PubMed - indexed for MEDLINE]Related articlesFree article

Vasculature and microenvironmental gradients: the missing links in novel approaches to cancer therapy?

Denekamp J, Daşu A, Waites A.

Adv Enzyme Regul. 1998;38:281-99.PMID: 9762359 [PubMed - indexed for MEDLINE]Related articles

Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB-like binding sites of the interleukin 8 gene.

Yasumoto K, Okamoto S, Mukaida N, Murakami S, Mai M, Matsushima K.

J Biol Chem. 1992 Nov 5;267(31):22506-11.PMID: 1331059 [PubMed - indexed for MEDLINE]Related articlesFree article

Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha.

Halin C, Gafner V, Villani ME, Borsi L, Berndt A, Kosmehl H, Zardi L, Neri D.

Cancer Res. 2003 Jun 15;63(12):3202-10.PMID: 12810649 [PubMed - indexed for MEDLINE]Related articlesFree article

The future role of anti-tumour necrosis factor (TNF) products in the treatment of rheumatoid arthritis.

Camussi G, Lupia E.

Drugs. 1998 May;55(5):613-20. Review.PMID: 9585859 [PubMed - indexed for MEDLINE]Related articles

Cytotoxicity of HSVtk and hrTNF-alpha fusion genes with IRES in treatment of gastric cancer.

Zhang JH, Wan MX, Pan BR, Yu B.

Cancer Lett. 2006 Apr 28;235(2):191-201.PMID: 16752439 [PubMed - indexed for MEDLINE]Related articles

Suppression of tumor angiogenesis through the inhibition of integrin function and signaling in endothelial cells: which side to target?

Rüegg C, Dormond O, Foletti A.

Endothelium. 2002;9(3):151-60. Review.PMID: 12380640 [PubMed - indexed for MEDLINE]Related articles